Metagenomi, Inc. Common StockMGXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -22.46% | -63.02% | -57.45% | -24.80% | -59.32% |
| Gross Profit Growth | +0.00% | +0.00% | -169.94% | -36.29% | -72.84% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -1.01% | -1.19% | -0.81% | +1.59% | +1.42% |
| Weighted Average Shares Diluted Growth | -1.01% | -1.19% | -0.81% | +1.59% | +1.42% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -48.71% | -51.39% | -47.03% | +62.99% | -75.74% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -11.03% | -28.29% | -29.44% | -30.81% | -31.88% |
| Book Value per Share Growth | +0.00% | -21.92% | -26.72% | -31.32% | -33.42% |
| Debt Growth | -5.08% | -7.54% | -10.33% | -9.57% | -11.19% |
| R&D Expense Growth | -6.43% | -20.03% | -20.53% | -8.75% | -7.18% |
| SG&A Expenses Growth | -9.78% | -22.25% | -18.22% | -18.66% | -22.56% |